Eupraxia Pharmaceuticals Insider Trading

TSXEPRXCompany Website
$000KBuys (1)
$0Sells (0)
HealthcareSector
BiotechnologyIndustry
$619.8MMarket Cap
7.68 – 12.5952 Week Range
97KAvg. Volume
Nov 3, 2026Next Earnings
▼ Filters▲
InsiderTagTrans DateFile DateSharesPriceValueIncreaseBalance
Montalbano, John
Director
NT19-Aug-2619-Aug-2600,000$0.00USD$000,0000%0,000,000
Pimstone, Simon
Chairman
SI27-Mar-2627-Mar-2600,000$0.00$000,00000%00,000
Freedman, Joseph
Director
NT18-Mar-2618-Mar-2600,000$00.00$000,0000%000,000
Brennan, Paul
Chief Development Officer
SI24-Nov-2526-Nov-2500,000$0.00$000,00000%00,000

Eupraxia Pharmaceuticals (EPRX): Stock Chart

▲ Buys
$█.██
$█.██
$█.██
$█.██
$█.██

Volume (thousands)

Related Companies to Explore

Glass House BrandsGLAS-ACuraleaf HoldingsCURAVector Science and TherapeuticsPAINCopland Road CapitalCRCCCheelcareCHEROrganigram GlobalOGI